Nuvalent CSO Henry E. Pelish Executes Stock Option Exercise and Stock Sales

Henry E. Pelish, Chief Scientific Officer of Nuvalent, Inc., filed a Form 4 on April 13, 2026, reporting transactions from April 9, 2026. Pelish exercised stock options for 3,093 shares at $27.85 per share and simultaneously sold those shares along with additional holdings. He sold 2,193 shares at a weighted average price of $104.27 and 900 shares at $105.00 per share. All transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025. Following these transactions, Pelish's direct holdings in Nuvalent Class A Common Stock decreased from 68,697 shares to 65,604 shares, while he retains 8,309 stock options. The option exercise involved shares that vest over four years following January 6, 2023, subject to continued service.